The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways

Nutrition and Cancer

Volumn 62, Issue 4, 2010, Pages 533-542

  Saggar, Jasdeep Kaur ^a   Chen, Jianmin ^a   Corey, Paul ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGNAN DERIVATIVE; LINSEED OIL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN PS2; SECOISOLARICIRESINOL DIGLUCOSIDE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; BUTYLENE GLYCOLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSIDES; HUMANS; LINSEED OIL; MICE; MICE, NUDE; PHYTOESTROGENS; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 77951996148     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903532440     Document Type: Article

References (47)

1. Boon HS, Olatunde F, and Zick SM: Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Women's Health 7, 4, 2007.
2. Thompson LU, Robb P, Serraino M, and Cheung F: Mammalian lignan production from various foods. Nutr Cancer 16, 43-52, 1991.
3. Thompson LU: Flaxseed, lignans, n-3 fatty acids and drug synergy in the prevention and treatment of cancer. In: Food-Drug Synergy and Safety, Thompson LU and Ward WE (eds.). Boca Raton, FL: CRC Press, 2006, pp. 147-169.
4. Bougnoux P and Chajes V: Alpha-linolenic acid and cancer. In: Flaxseed in Human Nutrition, Cunnane SC and Thompson LU (eds.), 2nd ed. Champaign, IL: AOCS Press, 2003, pp. 232-244.
5. Adlercreutz H: Lignans and human health. Crit Rev Clin Lab Sci 44, 483-525, 2007.
6. Power KA and Thompson LU: Flaxseed and lignans: Effects on breast cancer. In: Nutrition and Cancer Prevention, Awad A and Bradford PG (eds.). Boca Raton, FL: CRC press, 2006, pp. 385-410.
7. Thompson LU, Rickard SE, Orcheson LJ, and Seidl MM: Flaxseed and its lignan and oil components reduce mammary growth at a late stage of carcinogenesis. Carcinogenesis 17, 1373-76, 1996.
8. Serraino M and Thompson LU: The effect of flaxseed in early risk markers for mammary carcinogenesis. Cancer Lett 60, 135-142, 1991.
9. Serraino M and and Thompson LU: The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 17, 153-159, 1992.
10. Thompson LU, Chen JM, Li T, Stasser-Weippkl K, and Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 11, 3828-3835, 2005.
11. Chen J, Wang L, and Thompson LU: Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett 234, 168-175, 2006.
12. Chen J, Stavro PM, and Thompson LU: Dietary flaxseed inhibits breast cancer growth and metastasis and downregulates expression of the insulinlike growth factor and epidermal growth factor receptor. Nutr Cancer 43, 187-192, 2002. (Pubitemid 36134093)
13. Wang L, Chen J, and Thompson LU: The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer 116, 793-798, 2005.
14. Dabrosin C, Chen J, Wang L, and Thompson LU: Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett 185, 31-37, 2002.
15. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L, et al.: Enterolactone inhibits the growth of 7, 12-dimethylbenzantracene-induced mammary carcinomas in the rat. Molec Cancer Therapeut 1, 869-876, 2002.
16. Power KA, Saarinen NM, Chen J, and Thompson LU: Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 118, 1316-1320, 2006.
17. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong H H S, et al.: Dosedependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126, 2012-2019, 1996.
18. Reeves PG, Nielsen FH, and Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
19. Chen J, Hui E, Ip T, and Thompson LU: Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 10, 7703-7711, 2004.
20. Allred DC, Harvey JM, Berardo M, and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11, 155-168, 1998.
21. Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Dietary flaxseed interaction with tamoxifen induced tumor regression in nude mice with MCF-7 xenografts by down-regulating the expression of estrogen related gene products and signal transduction pathways. Nutr Cancer 58, 162-170, 2007.
22. Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med (Maywood) 232, 1071-1080, 2007.
23. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, and Fong HH: Antitumorigenic effect of mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159-165, 1996.
24. Rickard SE, Yuan YV, Chen J, and Thompson LU: Dose effects of flaxseed and its lignan on methyl-n-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 35, 50-57, 1999.
25. Björnström L and Sjöberg M: Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19, 833-842, 2005.
26. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, et al.: Diet-derived polyphenol metabolite enterolactone is a tissuespecific estrogen receptor activator. Endocrinology 148, 4875-4886, 2007.
27. Zhu BT, Han GZ, Shim JY, Wen Y, and Jiang XR: Quantitative structureactivity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 147, 4132-4150, 2006.
28. Kang JS, Kim S, Che JH, Nam KT, Kim DJ, et al.: Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta. Oncol Rep 12, 689-693, 2004.
29. Leygue E, Dotzlaw H, Watson PH, and Murphy LC: Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58, 3197-3201, 1998.
30. Brandenberger AW, Tee MK, and Jaffe RB: Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 83, 1025-1028, 1998.
31. Roy PG and Thompson AM: Cyclin D1 and breast cancer. Breast 15, 718-727, 2006.
32. Fox EM, Andrade J, and Shupnik MA: Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathways. Steroids 74, 622-627, 2009.
33. Massarweh S, Osborne CK, Creighton CJ, Qin L, Tsimelzon A, et al.: Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res 68, 826-833, 2008.
34. Callagy GM, Webber MJ, Pharoah PD, and Caldas C: Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 8, 153, 2008.
35. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, et al.: Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19, 7203-7215, 1999.
36. Rickard SE, Yuan YV, and Thompson LU: Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 161, 47-55, 2000.
37. Xia Y, Jin L, Zhang B, Xue H, Li Q, et al.: The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. Life Sci 80, 2161-2169, 2007.
38. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al.: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595, 1987.
39. Bergman Jungeström M, Thompson LU, and Dabrosin C: Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13, 1061-1067, 2007.
40. Elkin M, Orgel A, and Kleinman HK: An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 96, 875-878, 2004.
41. Kitts DD, Yuan YV, Wijewickreme AN, and Thompson LU: Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol and Cel Biochem 202, 91-100, 1999.
42. Gago-Dominguez M, Jiang X, and Castelao JE: Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res 9, 201, 2007.
43. Hardman WE, Munoz J Jr, and Cameron IL: Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice. Cancer Cell Int 2, 10, 2002.
44. Cognault S, Jourdan ML, Germain E, Pitavy R, Morel E, et al.: Effect of an alpha-linolenic acid-rich diet on rat mammary tumor growth depends on the dietary oxidative status Nutr Cancer 36, 33-41, 2000.
45. Bruce-Keller AJ, Begley JG, Fu W, Butterfield DA, Bredesen DE, et al.: Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide J Neurochem 70, 31-39, 1998.
46. Escrich E, Moral R, Grau L, Costa I, and Solanas M: Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res 51, 1279-1292, 2007.
47. Larsson SC, Kumlin M, Ingelman-Sundberg M, and Wolk A: Dietary longchain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935-945, 2004.